Berberine promotes the development of atherosclerosis and foam cell formation by inducing scavenger receptor a expression in macrophage

Cell Research

Volumn 19, Issue 8, 2009, Pages 1006-1017

  Li, Ke ^a   Yao, Wenqi ^a   Zheng, Xiudan ^a   Liao, Kan ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

Atherosclerosis; Berberine; Macrophage foam cell; PI3 kinase PTEN; Scavenger receptor A

Indexed keywords

APOLIPOPROTEIN E; BERBERINE; LOW DENSITY LIPOPROTEIN RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; SCAVENGER RECEPTOR A;

ANIMAL; ARTICLE; ATHEROSCLEROSIS; C57BL MOUSE; DRUG EFFECT; FOAM CELL; GENETICS; MACROPHAGE; METABOLISM; MOUSE; MOUSE MUTANT; PATHOLOGY; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BERBERINE; FOAM CELLS; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PTEN PHOSPHOHYDROLASE; RECEPTORS, LDL; SCAVENGER RECEPTORS, CLASS A; SIGNAL TRANSDUCTION;

CRICETINAE; MUS;

EID: 68749104337     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2009.76     Document Type: Article

References (47)

1. Grundy SM. Statin trials and goals of cholesterol-lowering therapy. Circulation 1998; 97:1436-1439.
2. McKenney JM. Lovastatin: a new cholesterol-lowering agent. Clin Pharm 1988; 7:21-36.
3. Miura S, Saku K. Ezetimibe, a selective inhibitor of the transport of cholesterol. Intern Med 2008; 47:1165-1170.
4. Grigore L, Norata GD, Catapano AL. Combination therapy in cholesterol reduction: focus on ezetimibe and statins. Vasc Health Risk Manag 2008; 4:267-278.
5. Kong W, Wei J, Abidi P, et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med 2004; 10:1344-1351.
6. Abidi P, Zhou Y, Jiang JD, Liu J. Extracellular signal-regulated kinase-dependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medicine berberine. Arterioscle Thromb Vasc Biol 2005; 25:2170-2176.
7. Lee YS, Kim WS, Kim KH, et al. Berberine, a natural plant product, activates AMP-activated protein kinase with benef-cial metabolic effects in diabetic and insulin-resistant states. Diabetes 2006; 55:2256-2264.
8. Huang C, Zhang Y, Gong Z, et al. Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARgamma pathway. Biochem Biophys Res Commun 2006; 348:571-578.
9. Glass CK, Witztum JL. Atherosclerosis: the road ahead. Cell 2001; 104:503-516.
10. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362:801-809.
11. Ross R. Atherosclerosis: an infammatory disease. N Engl J Med 1999; 340:115-126.
12. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320:915-924.
13. Quinn MT, Parthasarathy S, Fong LG, Steinberg D. Oxidatively modifed low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci USA 1987; 84:2995-2998.
14. Frostegard J, Nilsson J, Haegerstand A, Hamsten A, Wigzell H, Gidlund M. Oxidized low density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937. Proc Natl Acad Sci USA 1990; 87:904-908.
15. Bobryshev YV. Monocyte recruitment and foam cell formation in atherosclerosis. Micron 2006; 37:208-222.
16. Pataki M, Lusztig G, Robenek H. Endocytosis of oxidized LDL and reversibility of migration inhibition in macrophage-derived foam cells in vitro. A mechanism for atherosclerosis regression? Arterioscler Thromb 1992; 12:936-944.
17. de Villiers WJ, Smart EJ. Macrophage scavenger receptors and foam cell formation. J Leukoc Biol 1999; 66:740-746.
18. Qiao JH, Tripathi J, Mishra NK, et al. Role of macrophage colony-stimulating factor in atherosclerosis: studies of osteo-porotic mice. Am J Path 1997; 150:1687-1699.
19. Smith JD, Trogan E, Ginsberg M, Grigaux C, Tian J, Miyata M. Decreased atherosclerosis in mice defcient in both macrophage colony stimulating factor (op) and apolipoprotein E. Proc Natl Acad Sci USA 1995; 92:8264-8268.
20. Goldstein JL, Ho YK, Basu SK, Brown MS. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA 1979; 76:333-337.
21. van Berkel TJ, Out R, Hoekstra M, Kuiper J, Biessen E, van Eck M. Scavenger receptors: friend or foe in atherosclerosis? Curr Opin Lipidol 2005; 16:525-535.
22. Kunjathoor V V, Febbraio M, Podrez EA, et al. Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modifed low density lipoprotein leading to lipid loading in macrophages. J Biol Chem 2002; 277:49982-49988.
23. Takahashi K, Takeya M, Sakashita N. Multifunctional roles of macrophages in the development and progression of athero- sclerosis in humans and experimental animals. Med Electron Microsc 2002; 35:179-203.
24. Han CY, Pak YK. Oxidation-dependent effects of oxidized LDL: proliferation or cell death. Exp Mol Med 1999; 31:165-173.
25. Piedrahita JA, Zhang SH, Hagaman JR, Oliver PM, Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Proc Natl Acad Sci USA 1992; 89: 4471-4475.
26. Plump AS, Smith JD, Hayek T, et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-defcient mice created by homologous recombination in ES cells. Cell 1992; 71: 343-353.
27. Reddick RL, Zhang SH, Maeda N. Atherosclerosis in mice lacking Apo E: evaluation of lesional development and progression. Arterioscler Thromb 1994; 14:141-147.
28. Zeng X, Zeng X. Relationship between the clinical effects of berberine on severe congestive heart failure and its concentration in plasma studied by HPLC. Biomed Chromatogr 1999; 13:442-444.
29. Leslie NR, Downes CP. PTEN function: how normal cells control it and tumour cells lose it. Biochem J 2004; 382(Pt 1):1-11.
30. Vlahos CJ, Matter WF, Hui KY, Brown RF. A specifc inhibitor of phosphatidylinositol3-kinase 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 1994; 269:5241-5248.
31. Patel L, Pass I, Coxon P, Downes CP, Smith SA, Macphee CH. Tumor suppressor and anti-inflammatory actions of PPARgamma agonists are mediated via upregulation of PTEN. Curr Biol 2001; 11:764-768.
32. Lee SY, Hur GY, Jung KH, et al. PPAR-gamma agonist increase geftinib's antitumor activity through PTEN expression. Lung Cancer 2006; 51:297-301.
33. MacDougald OA, Lane MD. Transcriptional regulation of gene expression during adipocyte differentiation. Annu Rev Biochem 1995; 64:345-373.
34. Tontonoz P, Hu E, Spiegelman BM. Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma. Curr Opin Genet Dev 1995; 5:571-576.
35. Kleemann R, Zadelaar S, Kooistra T. Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovasc Res 2008; 79:360-376.
36. Lee CH, Chen JC, Hsiang CY, Wu SL, Wu HC, Ho TY. Berberine suppresses inflammatory agents-induced interleukin-1beta and tumor necrosis factor-alpha productions via the inhibition of IkappaB degradation in human lung cells. Pharmacol Res 2007; 56:193-201.
37. Zhou H, Mineshita S. The effect of berberine chloride on experimental colitis in rats in vivo and in vitro. J Pharmacol Exp Ther 2000; 294:822-829.
38. Li F, Wang HD, Lu DX, et al. Neutral sulfate berberine modulates cytokine secretion and increases survival in endotoxemic mice. Acta Pharmacol Sin 2006; 27:1199-1205.
39. Cao MW, Murao K, Imachi H, et al. Phosphatidylinositol 3-OH kinase-Akt/protein kinase B pathway mediates Gas6 induction of scavenger receptor a in immortalized human vascular smooth muscle cell line. Arterioscler Thromb Vasc Biol 2001; 21:1592-1597.
40. Van Eck M, De Winther MP, Herijgers N. et al. Effect of human scavenger receptor class A overexpression in bone marrow-derived cells on cholesterol levels and atherosclerosis in ApoE-defcient mice. Arterioscler Thromb Vasc Biol 2000; 20:2600-2606.
41. Takahashi N, Kawada T, Goto T, et al. Abietic acid activates peroxisome proliferator-activated receptor-gamma (PPAR-gamma) in RAW264.7 cells and 3T3-L1 adipocytes to regulate gene expression involved in infammation and lipid metabolism. FEBS Lett 2003; 550:190-194.
42. Sarén P, Welgus HG, Kovanen PT. TNF-alpha and IL-1beta selectively induce expression of 92-kDa gelatinase by human macrophages. J Immunol 1996; 157:4159-4165.
43. Kaakinen R, Lindstedt KA, Sneck M, Kovanen PT, Orni K. Angiotensin II increases expression and secretion of cathep-sin F in cultured human monocyte-derived macrophages: an angiotensin II type 2 receptor-mediated effect. Atherosclerosis 2007; 192:323-327.
44. Mizoguchi T, Edano T, Koshi T. A method of direct measurement for the enzymatic determination of cholesteryl esters. J Lipid Res 2004; 45:396-401.
45. Hong S, Huo H, Xu J, Liao K. Insulin-like growth factor-1 receptor signaling in 3T3-L1 adipocyte differentiation requires lipid rafts but not caveolae. Cell Death Differ 2004; 11:714-723.
46. Jin S, Zhai B, Qiu Z, Wu J, Lane MD, Liao K. c-Crk, a substrate of the insulin-like growth factor-1 receptor tyrosine kinase, functions as an early signal mediator in the adipocyte differentiation process. J Biol Chem 2000; 275:34344-34352.
47. de la Llera Moya M, Atger V, Paul JL, et al. A cell culture system for screening human serum for ability to promote cellular cholesterol effux. Arterioscler Thromb 1994; 14:1056-1065.